Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study

Abroad (travel likely)Recruiting

Conditions

Alopecia Areata · Janus Kinase Inhibitors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Second Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou, Zhejiang, China
Contact: Study coordinator (Ru Dai, Ph.D) · dairu@zju.edu.cn · 86 15982215914

Study leads

Xianjie Wu, Ph.D
Principal Investigator
Second Affiliated Hospital, School of Medicine, Zhejiang University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia Areata

Alopecia Areata

Abroad (travel likely)RecruitingPHASE3

Asahikawa, Japan · Bunkyō City, Japan

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

Severe Alopecia Areata

Abroad (travel likely)RecruitingPHASE3

Encinitas, United States · Miami, United States

Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome

Atopic Dermatitis · Alopecia Areata

Abroad (travel likely)RecruitingPHASE2

New York, United States

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata

Alopecia Areata

Abroad (travel likely)RecruitingPHASE3

Nagoya, Japan · Kurume-shi, Japan